Premium Nahrungsergänzungsmittel | artgerecht

Decarboxylase – Function, Types and Medical Role

Decarboxylases are enzymes that remove carboxyl groups from organic molecules, releasing CO2. They play a key role in metabolism and neurotransmitter synthesis.

Regular tips about health Regular tips about health

Things worth knowing about "Decarboxylase"

Decarboxylases are enzymes that remove carboxyl groups from organic molecules, releasing CO2. They play a key role in metabolism and neurotransmitter synthesis.

What Is a Decarboxylase?

A decarboxylase is an enzyme that catalyzes the biochemical reaction known as decarboxylation. During this reaction, a carboxyl group (-COOH) is removed from an organic molecule, releasing carbon dioxide (CO₂) as a byproduct. Decarboxylases belong to the enzyme class of lyases and are found in virtually all living organisms, from bacteria to humans.

Biological Importance

Decarboxylases serve a wide range of vital functions in the human body and are involved in numerous metabolic pathways, including:

Neurotransmitter synthesis: Aromatic L-amino acid decarboxylase (AADC) converts L-DOPA into dopamine and L-5-hydroxytryptophan (5-HTP) into serotonin.
Energy metabolism: Pyruvate decarboxylase catalyzes the conversion of pyruvate to acetaldehyde during fermentation; in humans, the pyruvate dehydrogenase complex performs an analogous role in the citric acid cycle.
Amino acid metabolism: Glutamate decarboxylase (GAD) converts glutamate into the inhibitory neurotransmitter GABA (gamma-aminobutyric acid).
Histamine production: Histidine decarboxylase converts the amino acid histidine into histamine, which plays a central role in immune and allergic responses.

Key Decarboxylases at a Glance

Aromatic L-Amino Acid Decarboxylase (AADC)

This enzyme is essential for the biosynthesis of the biogenic amines dopamine and serotonin. A deficiency in AADC leads to a rare neurological disorder characterized by movement abnormalities, autonomic dysfunction, and developmental delays.

Glutamate Decarboxylase (GAD)

Glutamate decarboxylase is responsible for producing GABA, the primary inhibitory neurotransmitter in the central nervous system. Autoantibodies against GAD are detected in type 1 diabetes and certain neurological autoimmune conditions such as stiff person syndrome.

Ornithine Decarboxylase (ODC)

Ornithine decarboxylase is the rate-limiting enzyme in polyamine biosynthesis. Polyamines such as spermine and spermidine are essential for cell growth and division. ODC is overexpressed in several cancers and is therefore considered a potential target for anticancer therapies.

Pyruvate Decarboxylase

This decarboxylase is found primarily in yeasts and plants, where it catalyzes alcoholic fermentation. In humans, the pyruvate dehydrogenase complex performs a functionally analogous role in connecting glycolysis to the citric acid cycle.

Cofactors and Regulation

Many decarboxylases require cofactors to function. The most common cofactor is pyridoxal phosphate (PLP), the active form of vitamin B6. A deficiency in vitamin B6 can therefore impair the activity of numerous decarboxylases, leading to disruptions in neurotransmitter balance. Enzyme activity is also regulated by substrate concentration, product inhibition, and hormonal signaling.

Clinical Relevance

Decarboxylases are clinically significant for several reasons:

Pharmacological targets: Inhibitors of specific decarboxylases are used therapeutically. For example, carbidopa inhibits peripheral AADC to increase the bioavailability of L-DOPA in the treatment of Parkinson disease.
Diagnostic markers: Anti-GAD antibodies serve as biomarkers for type 1 diabetes and neurological autoimmune conditions.
Tumor biology: Overexpression of ornithine decarboxylase is associated with increased cell proliferation in various tumor types.
Inborn errors of metabolism: Genetic defects in decarboxylase genes can cause rare but severe metabolic diseases.

References

Stryer, L., Berg, J. M., Tymoczko, J. L. (2015). Biochemistry. 8th edition. W. H. Freeman and Company, New York.
Brun, L. et al. (2010). AADC deficiency: from gene to clinic. Journal of Inherited Metabolic Disease, 33(6), 751-762. PubMed PMID: 20740320.
Erlander, M. G., Tobin, A. J. (1991). The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochemical Research, 16(3), 215-226. PubMed PMID: 1712387.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.